Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning

Launched by STATE INSTITUTION "REPUBLICAN SCIENTIFIC AND PRACTICAL CENTER" CARDIOLOGY, BELARUS · Apr 4, 2023

Keywords

ClinConnect Summary

This clinical trial is investigating a condition called Cerebral Hyperperfusion Syndrome (CHS) that can occur after procedures to open blocked carotid arteries, which are the main arteries that supply blood to the brain. CHS can cause various symptoms, such as severe headaches, confusion, and even visual problems. The study aims to use advanced computer technology, known as deep learning, to better predict who may develop this syndrome after surgery. Understanding this can help doctors recognize and treat CHS early, improving patient outcomes.

To participate in the trial, individuals aged between 30 and 80 who have significant narrowing of their carotid arteries—either with symptoms or without—may be eligible. Participants will undergo assessments and monitoring to help researchers gather important data related to CHS. It's important to note that the study is currently recruiting participants in Belarus. If you or a loved one meet the criteria and are interested, this trial could provide valuable insights into managing this condition more effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age from 30 to 80 years
• • 2. Has a symptomatic (more than 60%) or a asymptomatic (more than 70%) carotid stenosis
• • 3. Permanent residence in the Republic of Belarus
• Exclusion Criteria:
• • 1. Patient's unwillingness to continue participating in the study
• • 2. Absence of a temporal window for transcranial dopplerography